Cargando…
Interleukin-2 inducible T-cell kinase: a potential prognostic biomarker and tumor microenvironment remodeling indicator for hepatocellular carcinoma
Background: The heterogeneous tumor microenvironment (TME) contributes to poor prognosis of hepatocellular carcinoma (HCC). However, determining the modulation of TME during HCC progression remains a challenge. Methods: Herein, the stromal score and immune score of HCC samples from The Cancer Genome...
Autores principales: | Pan, Binhua, Yang, Modan, Wei, Xuyong, Li, Wangyao, Wang, Kun, Yang, Mengfan, Lu, Di, Wang, Rui, Cen, Beini, Xu, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351695/ https://www.ncbi.nlm.nih.gov/pubmed/34282055 http://dx.doi.org/10.18632/aging.203306 |
Ejemplares similares
-
Proteomics‐based identification of the role of osteosarcoma amplified‐9 in hepatocellular carcinoma recurrence
por: Wei, Xuyong, et al.
Publicado: (2022) -
The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma
por: Lu, Di, et al.
Publicado: (2020) -
Development of a Novel Prognostic Nomogram for High Model for End-Stage Liver Disease Score Recipients Following Deceased Donor Liver Transplantation
por: Yang, Mengfan, et al.
Publicado: (2022) -
Stratified Analysis of Survival Benefit for ABO-incompatible Deceased-donor Liver Transplantation: Multicenter Propensity Score-matched Study
por: Yang, Mengfan, et al.
Publicado: (2023) -
The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
por: Zhuo, Jianyong, et al.
Publicado: (2021)